1. 179P Early proof of concept of safety and clinical activity of clonal neoantigen-reactive T cells (cNeT). (December 2022) Authors: Forster, M.D.; Cave, J.; Greystoke, A.; Plummer, R.; Spicer, J.; Thistlethwaite, F.; Turajlic, S.; Craig, A.; Newton, K.; Saggese, M.; Quezada, S.; Peggs, K. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BRENTUXIMAB VEDOTIN FOR RELAPSED HODGKIN LYMPHOMA AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: a RETROSPECTIVE STUDY OF THE EBMT LYMPHOMA WORKING PARTY. (June 2017) Authors: Bazarbachi, A.; Boumendil, A.; Finel, H.; Mohty, M.; Castagna, L.; Blaise, D.; Peggs, K.; Afanasyev, B.; Diez‐Martin, J.; Corradini, P.; Socié, G.; Robinson, S.; Gutiérrez‐García, G.; Bonifazi, F.; Yakoub‐Agha, I.; Gülbas, Z.; Bloor, A.; Delage, J.; Esquirol, A.; Malladi, R. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DONOR LYMPHOCYTE INFUSIONS INDUCE DURABLE RESPONSES IN PATIENTS WITH FOLLICULAR, MANTLE AND T CELL LYMPHOMAS RELAPSING AFTER AN ALLOSCT. AN EBMT‐LWP STUDY. (12th June 2019) Authors: Robinson, S.; Boumendil, A.; Finel, H.; Khvedelidze, I.; Kanfer, E.; Peggs, K.; Fuesrt, S.; Ram, R.; Marjit, E.; Vandenberghe, E.; Afanasyev, B.; Wulf, G.; Maertens, J.; Tsolukani, A.; Schapp, N.; Beelen, D.; Chalandon, Y.; Gurman, G.; Finke, J.; Bron, D. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P1459: SAFETY AND EFFICACY FINDINGS OF AUTO1, A FAST-OFF RATE CD19 CAR, IN RELAPSED/REFRACTORY B-CELL NON-HODGKIN'S LYMPHOMA (B-NHL), AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) / SMALL LYMPHOCYTIC LYMPHOMA (SLL). (23rd June 2022) Authors: Roddie, C.; Dias, J.; O'Reilly, M.; Mitsikakou, M.; Charalambous, E.; Green, L.; Vaughan, M.; Agliardi, G.; Garcia, J.; Lewin, E.; Lowdell, M.; Marzolini, M.; Wood, L.; Holmes, H.; Ngai, Y.; Popova, B.; Wilson, W.; Kunaseelan, S.; Spanswick, V.; Lowe, H. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1460: SAFETY AND EFFICACY FINDINGS OF AUTO1, A FAST-OFF RATE CD19 CAR, IN RELAPSED/REFRACTORY PRIMARY CNS LYMPHOMA. (23rd June 2022) Authors: Roddie, C.; Dias, J.; O'Reilly, M.; Green, L.; Vaughan, M.; Agliardi, G.; Garcia, J.; Lewin, E.; Lowdell, M.; Mitsikakou, M.; Charalambous, E.; Hotblack, A.; Dreau, H.; Marzolini, M.; Wood, L.; Every-Clayton, C.; Lal, A.; Ngai, Y.; Popova, B.; Malhi, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. RESULTS OF a MULTICENTRE UK‐WIDE STUDY EVALUATING THE EFFICACY OF BRENTUXIMAB VEDOTIN IN RELAPSED, REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN THE PRE‐TRANSPLANT NAÏVE SETTING. (June 2017) Authors: Eyre, T.A.; Phillips, E.H.; Linton, K.M.; Kassam, S.; Gibb, A.; Allibone, S.; Peggs, K.; Burton, C.; Stewart, G.; Ledieu, R.; Booth, C.; Osborne, W.; Miall, F.; Eyre, D.W.; Ardeshna, K.; Collins, G.P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. TARGETING THE T‐CELL RECEPTOR Β‐CONSTANT DOMAIN FOR IMMUNOTHERAPY OF T‐CELL MALIGNANCIES. (June 2017) Authors: Maciocia, P.M.; Wawrzyniecka, P.; Philip, B.; Ricciardelli, I.; Akarca, A.; Onohua, S.; Cole, D.; Sewell, A.; Peggs, K.; Linch, D.; Marafioti, T.; Pule, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. THE EFFICACY OF IBRUTINIB IN PATIENTS WITH RELAPSED MANTLE CELL LYMPHOMA AFTER FIRST LINE INTENSIVE CHEMO‐IMMUNOTHERAPY AND ASCT – A RETROSPECTIVE STUDY FROM THE LWP‐EBMT. (12th June 2019) Authors: Burney, C.N.; Robinson, S.; Boumendil, A.; Finel, H.; Khvedelidze, I.; Hunter, H.; Poire, X.; Lioure, B.; Peggs, K.; Foa, R.; Pillai, S.; van Meerten, T.; Bargay Lleonart, J.; Schmid, C.; Vergote, V.; Ganser, A.; Castagna, L.; Mufti, G.; Montoto, S. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗